Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university’s Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a five-year, $4.1 million federal grant to develop a drug targeting Ebola virus.
Having high levels of a certain biomarker is linked to poor prognosis in African-American patients with triple-negative breast cancer, while the same biomarker doesn’t influence disease outcomes in white patients, according to a new study.
Racial disparities in disease, particularly breast cancer, continue to pose a major challenge in healthcare. African-American breast cancer patients are… more »
Emulsifiers, which are added to most processed foods to aid texture and extend shelf life, can alter intestinal bacteria in a manner that promotes intestinal inflammation and colorectal cancer, according to a new study.
The findings, published in the journal Cancer Research, show regular consumption of dietary emulsifiers in mice exacerbated tumor development. The study… more »
Georgia State University has unveiled its newest state-of-the-art research facility, the Research Science Center, to support biomedical research.
The $45 million building will house up to four principal investigators and their faculty and staff, as well as postdoctoral scholars, graduate students and undergraduate students. The center, constructed without the use of taxpayer funds, is at… more »
Users of both electronic nicotine delivery systems (ENDS) and cigarettes may be more intent on quitting tobacco, but that intention seems to drop off among less educated smokers, according to a study by Georgia State University researchers published in the journal Addictive Behaviors.
Edible ginger-derived nano-lipids created from a specific population of ginger nanoparticles show promise for effectively targeting and delivering chemotherapeutic drugs used to treat colon cancer, according to a study by researchers at the Institute for Biomedical Sciences at Georgia State University, the Atlanta Veterans Affairs Medical Center and Wenzhou Medical University and Southwest University in… more »
Certain viruses, such as influenza, could survive on children’s toys long enough to result in exposures, placing children at risk for getting infectious diseases, according to researchers at Georgia State University.
The researchers tested how long an enveloped virus could survive on pieces of a flexible plastic children’s toy, a squeaking frog. They were able… more »
A study led by researchers at Georgia State University provides new insights into the molecular basis of human diseases resulting from mutations in the calcium-sensing receptor (CaSR), a protein found in cell membranes.
A protein designed by researchers at Georgia State University can effectively target a cell surface receptor linked to a number of diseases, showing potential as a therapeutic treatment for an array of illnesses, including cancer, according to the research team.
ProAgio, which is created from a human protein, targets the cell surface receptor integrin αVβ₃… more »